ANP popped up on a scan earlier in the week and had a look to do some personal DD.
Posted it as part of a few scan charts on the STT few days ago.
Quick chart thoughts fwiw at the mo and appears a bit of broker reporting coming on as per qtrly with this from stock head a couple of days ago.
Any BO obviously will need volume support to drive.
https://unauthorised investment advice/health/scopos-powerplays-solid-earnings-on-health-stocks-all-round-but-price-action-stays-with-larger-caps/Stock of the week
Power’s stock of the week isAntisense Therapeutics (ASX:ANP).
The company has received positive feedback from the Type-C meeting with the US FDA (trial design, dosage, endpoints were all acceptable) on its Phase-2 ATL1102 trial, with the decision on fast designation request expected in August.
ATL1102 is an antisense inhibitor to treat Duchenne Muscular Dystrophy (DMD), a fatal genetic muscle inflammation disorder that affects every 3,500 to 5,000 males worldwide.
“The other area of interest with Antisense is that its long-serving chairman Bob Moses is stepping down to make way for Dr Charmaine Gittleson, a very highly credentialed executive from CSL,” Power said.
Chart, page-3835
-
-
- There are more pages in this discussion • 2,071 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.004(5.26%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.7¢ | $35.48K | 451.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 198147 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1471 | 0.077 |
1 | 69866 | 0.074 |
1 | 75000 | 0.073 |
2 | 15000 | 0.070 |
1 | 100000 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 198147 | 2 |
0.081 | 198015 | 2 |
0.082 | 75174 | 2 |
0.083 | 93000 | 1 |
0.084 | 200300 | 2 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |